Abstract:Cushing’s Disease (CD) is a rare condition characterized by an overproduction of ACTH by an ACTH-secreting pituitary tumor, resulting in an excess of cortisol release by the adrenal glands. Somatic mutations in the deubiquitinases USP8 and USP48, and in BRAF genes, have been reported in a subset of patients affected by CD. The aim of this study was to characterize the genetic profile of a cohort of 60 patients with ACTH-secreting tumors, searching for somatic mutations in USP8, USP48, and BRAF hotspot regions. Seven patients were found to carry USP8 somatic mutations in the well-characterized 14-3-3 protein binding motif (n = 5 P720R, n = 1 P720Q, n = 1 S718del); 2 patients were mutated in USP48 (M415I); no mutation was identified in BRAF. In addition, a novel USP8 variant, G664R, located in exon 14, upstream of the 14-3-3 protein binding motif, was identified in 1 patient. Functional characterization of USP8 G664R variant was performed in murine corticotroph tumor AtT-20 cells. Transient transfection with the USP8 G664R variant resulted in a significant increase of ACTH release and cell proliferation (+114.5 ± 53.6% and +28.3 ± 2.6% vs. empty vector transfected cells, p < 0.05, respectively). Notably, USP8 proteolytic cleavage was enhanced in AtT-20 cells transfected with G664R USP8 (1.86 ± 0.58–fold increase of N-terminal USP8 fragment, vs. WT USP8, p < 0.05). Surprisingly, in situ Proximity Ligation Assay (PLA) experiments showed a significant reduction of PLA positive spots, indicating USP8/14-3-3 proteins colocalization, in G664R USP8 transfected cells with respect to WT USP8 transfected cells (−47.9 ± 6.6%, vs. WT USP8, p < 0.001). No significant difference in terms of ACTH secretion, cell proliferation and USP8 proteolytic cleavage, and 14-3-3 proteins interaction was observed between G664R USP8 and S718del USP8 transfected cells. Immunofluorescence experiments showed that, contrary to S718del USP8 but similarly to WT USP8 and other USP8 mutants, G664R USP8 displays an exclusive cytoplasmic localization. In conclusion, somatic mutations were found in USP8 (13.3% vs. 36.5% incidence of all published mutations) and USP48 (3.3% vs. 13.3% incidence) hotspot regions. A novel USP8 variant was identified in a CD patient, and in vitro functional studies in AtT-20 cells suggested that this somatic variant might be clinically relevant in ACTH-secreting tumor pathogenesis, expanding the characterization of USP8 functional domains.

Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report

Recurrent Gain-Of-Function Usp8 Mutations in Cushing'S Disease

Genotype-phenotype landscape of pituitary adrenocorticotroph hormone adenoma

Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene Variant

Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas.

A long-term prognosis study of human <i>USP8</i>-mutated ACTH-secreting pituitary neuroendocrine tumours

A long‐term prognosis study of human USP8‐mutated ACTH‐secreting pituitary neuroendocrine tumours

The molecular genetics of adrenal cushing

Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review

[Clinical and Genetic Analysis of a Case of Gitelman Syndrome with Comorbid Graves Disease and Adrenocortical Adenoma].

Cyclic Cushing’s Syndrome Caused by Neuroendocrine Tumor: a Case Report

Cushing's disease in children ( report of 1 case and review of literature)

Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells

A Novel Germline ARMC5 Mutation in a Patient with Bilateral Macronodular Adrenal Hyperplasia: a Case Report

Congenital Hypopituitarism Due to Novel Compound Heterozygous POU1F1 Gene Mutation: A Case Report and Review of the Literature

Pediatric pituitary neuroendocrine tumors-a 13-year experience in a tertiary center

Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation

Epco-35. Genomic Characterization Of Growth Hormone Secreting Pituitary Adenomas

Pituitary gigantism due to a novel AIP germline splice-site variant

[Clinical and Genetic Characteristics of a Young Child with Combined Pituitary Hormone Deficiency Type I Caused by POU1F1 Gene Variation].

Childhood adrenocortical tumor: A clinical and immunohistochemical study of 13 cases.